Arca Biopharma | ABIO - Des Atouts





Des Atouts Changement Date
Alterity Therapeutics Limited AUD 37.98M 15.78M 2025-12
Amgen USD 95.64B 3.14B 2026-06
Arca Biopharma USD 1.14B 634.91M 2026-06
Biogen USD 32.09B 2.6B 2026-06
Brainstorm Cell Therapeutics USD 788K 33K 2026-06
Bristol-Myers Squibb USD 87.63B 1.16B 2026-06
Capricor Therapeutics USD 368.74M 42.45M 2026-06
Cipla INR 424.96B 23.32B 2026-03
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 145.86M 10.71M 2026-03
CSL USD 37.9B 1.5B 2025-12
Cytokinetics USD 1.92B 651.07M 2026-06
Daiichi Sankyo JPY 4.11T 109.16B 2026-06
Gilead Sciences USD 49.36B 6.92B 2026-06
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
Grifols EUR 23.15B 142.7M 2025-12
Laboratory Of America USD 18.53B 554.8M 2026-06
Myriad Genetics USD 638.9M 34.8M 2026-06
Otsuka Holdings JPY 4.4T 186.7B 2026-06
Pfizer USD 201.13B 6.49B 2026-06
United Therapeutics USD 7.22B 505.9M 2026-06